INS and cardiovascular disorder: For example, certain diseases are bad outcomes for the treatment of specific diseases (e.g., clozapine and olanzapine, used for treating psychiatric disorders, can lead to insulin sensitivity and lipid metabolism changes, which increase the risk of diabetes and cardiovascular disease) [50].